Pharmac Proposal To Procure Drug-Eluting Stents Will Mean Savings For Public Hospitals

The proposed deal would award Principal Supply Status for permanent coronary drug-eluting stents for public hospitals to Medtronic New Zealand. Hospitals would be able to invest the proposed savings into new and emerging technologies.